White House delays revamped immigration order to next week —official

WASHINGTON - The White House has pushed back the release of a new executive order to replace its directive suspending travel to the United States by citizens of seven mostly Muslim countries, a White House official said on Wednesday.
The order is now expected to be issued "sometime next week," the official said. President Donald Trump said last week he expected to release the new order this week.
Trump said the new directive will address legal concerns raised in Washington state, San Francisco and elsewhere about the original order, which was issued on Jan. 27.
The order, which was quickly implemented, caused chaos at airports around the world as visa holders heading to the United States were pulled off planes or turned around upon arrival at US airports.
Americans were deeply divided over the order, which was condemned by prominent US companies and allies before being temporarily blocked by federal courts.
Trump criticized the court's action in a series of tweets, including one that read: "The opinion of this so-called judge, which essentially takes law-enforcement away from our country, is ridiculous and will be overturned!" —Reuters

Comments

Post a Comment

Popular posts from this blog

POPCOM, gagamit ng ‘digital platforms’ para pagtibayin ang mga ugnayang pampamilya

Mas pinalalawig ng Komisyon sa Populasyon at Pagpapaunlad (POPCOM) ang adhikain nitong pagpapalaganap at pagpapabuti ng pakikipag-ugnayan ng mga nakakatandang Pilipino sa kanilang mga anak na nagdadalaga at nagbibinata. Nitong Setyembre 21, ang POPCOM ay nagsagawa ng isang “parent-teen talk webinar” gamit ang Zoom, kung saan ang isang “interactive program” ang nagbigay ng naaayon na kaalaman at kasanayan sa mga magulang, habang tumulong ito sa mga anak na teenager na maabot ang kanilang buong potensyal. Hinikayat din nito ang mga nanay at tatay na sumali sa malayang usapan, lalo na sa mga usapin ukol sa sex at sekswalidad, na nakikitang makakatulong upang bumaba ang mga bilang ng mga pagbubuntis sa hanay ng mga kabataan. Maaaring mapanood ang webinar sa https://youtu.be/lZ9jrJCjYas. Ayon kay Ikalawang Kalihim (Undersecretary) Juan Antonio A. Perez III, MD, MPH, “ang webinar ay naging isang tagapag-simula at ‘padaluyan’ ng pag-uu
Read more

In Cairo, senior Hamas officials discuss hostage deal with Egyptian intelligence chief ---By TOI STAFF, AGENCIES and LAZAR BERMAN

Delegation said led by terror group’s Qatar-based political leader Ismail Haniyeh; Wall Street Journal reports Hamas demanding 150 security prisoners for each female soldier A delegation of senior Hamas officials arrived in Cairo on Thursday for talks with Egyptian officials on a possible deal that would see the release of hostages held by terrorists in Gaza. The delegation was led by Hamas political leader Ismail Haniyeh, who lives in Qatar, and included senior members Mousa Abu Marzook and Khalil al-Hayya, the Qatar-based Al-Araby news outlet reported, citing an unnamed Egyptian source. The Hamas officials met with the head of Egyptian intelligence, Major General Abbas Kamel, to discuss the details of a hostage deal proposal that was presented to the Gaza terror group earlier this week by Qatari and Egyptian mediators. The outline of the deal was drawn up during a meeting in Paris last week in the presence of Israeli and US officials, as well as Qatari and Egyptian negotiators, a
Read more

LIST: 21 medicines added to VAT-exempt list Ian Laqui - Philstar.com

Pixabay MANILA, Philippines — The Bureau of Internal Revenue (BIR) has expanded its list of medicines which are exempt from the value added tax (VAT). Revenue Memorandum Circular No. 17-2024 released by the tax bureau exempted 21 medications following the endorsement of the Food and Drug Administration. The VAT-exempted medications on the list are for conditions such as cancer, diabetes, high cholesterol, hypertension, kidney disease, mental illness and tuberculosis. Below is the full list of additional VAT-exempted medications: For cancer Panitumumab (100mg/5ml) (concentrate solution for infusion) Fulvestrant (50mg/ml) (concentrate solution for infusion) For diabetes Teneligliptin (as hydrobromide hydrate) (20 mg) Sitagliptin (as phospate monohydrate) + Metformin HCI (50mg/500mg) Sitagliptin (50 mg) Sitagliptin (10 mg) Metformin Hydrochloride (500 mg) For high cholesterol Atorvastatin Calcium (20 mg) Atorvastatin + Fenofibrate (40 mg/160 mg) For mental illness Desvenlafaxine
Read more